Ameriprise Financial Inc. Has $4.74 Million Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Ameriprise Financial Inc. lifted its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 10.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 249,246 shares of the medical instruments supplier's stock after acquiring an additional 23,053 shares during the quarter. Ameriprise Financial Inc. owned 0.13% of DENTSPLY SIRONA worth $4,735,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Riverview Trust Co purchased a new stake in shares of DENTSPLY SIRONA in the fourth quarter valued at about $26,000. MassMutual Private Wealth & Trust FSB raised its stake in DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock valued at $27,000 after acquiring an additional 1,232 shares during the last quarter. UMB Bank n.a. raised its stake in DENTSPLY SIRONA by 60.8% during the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock valued at $28,000 after acquiring an additional 564 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in DENTSPLY SIRONA by 700.0% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock worth $33,000 after acquiring an additional 1,568 shares during the period. Finally, Quarry LP grew its stake in shares of DENTSPLY SIRONA by 25.7% in the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock valued at $72,000 after purchasing an additional 780 shares during the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Stock Down 0.4%

NASDAQ XRAY traded down $0.07 on Friday, reaching $16.26. The stock had a trading volume of 314,402 shares, compared to its average volume of 2,959,360. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 1 year low of $12.16 and a 1 year high of $28.25. The business has a 50 day moving average price of $14.51 and a 200 day moving average price of $17.05. The company has a market capitalization of $3.24 billion, a price-to-earnings ratio of -7.86, a P/E/G ratio of 1.80 and a beta of 0.92.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, beating analysts' consensus estimates of $0.29 by $0.14. The company had revenue of $879.00 million for the quarter, compared to analyst estimates of $854.75 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The company's quarterly revenue was down 7.8% compared to the same quarter last year. During the same quarter last year, the firm posted $0.42 earnings per share. On average, analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 11th. Investors of record on Friday, June 27th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, June 27th. This represents a $0.64 annualized dividend and a dividend yield of 3.94%. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -14.10%.

Insider Buying and Selling at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier bought 15,142 shares of the company's stock in a transaction dated Monday, March 3rd. The stock was bought at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the transaction, the director now directly owns 81,971 shares in the company, valued at $1,353,341.21. The trade was a 22.66% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Company insiders own 0.50% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the company. Piper Sandler cut their target price on DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a research note on Wednesday, April 30th. Wells Fargo & Company decreased their target price on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a research report on Friday, February 28th. Morgan Stanley downgraded shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price objective on the stock. in a report on Tuesday, April 15th. Wall Street Zen raised shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Finally, UBS Group decreased their price target on DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating on the stock in a research note on Friday, May 9th. Eleven equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $20.36.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.